Development of a dendritic cell-based vaccine to enhance CD4+ T-cell responses to a breast tumour antigen
With 570,000 new cases in the world each year, breast cancer remains the commonest malignancy in women and comprises 18% of all female cancer. The failure of current therapies for the treatment of women with metastatic breast cancer has culminated in the emergence of immunotherapy as a potential mea...
| Main Author: | |
|---|---|
| Published: |
University of Leicester
2000
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.696728 |